Novel endogenous small molecules as the checkpoint controllers in inflammation and resolution: entrée for resoleomics.
about
Lipoxins: nature's way to resolve inflammationProtectins and maresins: New pro-resolving families of mediators in acute inflammation and resolution bioactive metabolomeChronic inflammatory diseases are stimulated by current lifestyle: how diet, stress levels and medication prevent our body from recoveringResolution of Cochlear Inflammation: Novel Target for Preventing or Ameliorating Drug-, Noise- and Age-related Hearing Loss.Altering the Anti-inflammatory Lipoxin Microenvironment: a New Insight into Kaposi's Sarcoma-Associated Herpesvirus Pathogenesis.Activation and resolution of periodontal inflammation and its systemic impact.LXA4 actions direct fibroblast function and wound closureSelf-limited versus delayed resolution of acute inflammation: temporal regulation of pro-resolving mediators and microRNAHost-mediated resolution of inflammation in periodontal diseases.Serum oxylipin profiles in IgA nephropathy patients reflect kidney functional alterations.Immune system in renal injury and repair: burning the candle from both ends?Peroxisome proliferator-activated receptors (PPARs) in dermatology: Challenge and promise.Pleiotropic effects of statins: the role of eicosanoid production.Natural resolution of inflammation.Omega-3 fatty acids as an adjunct for periodontal therapy-a review.Dietary essential α-linolenic acid and linoleic acid differentially modulate TNFα-induced NFκB activity in FADS2-deficient HEK-293 cells.Neutrophil Resolvin E1 Receptor Expression and Function in Type 2 Diabetes.Aerosol Gemcitabine after Amputation Inhibits Osteosarcoma Lung Metastases but Not Wound Healing.The Study of Pyridazine Compounds on Prostanoids: Inhibitors of COX, cAMP Phosphodiesterase, and TXA2Synthase
P2860
Q26784376-5D5E7E3D-29F2-4F86-95F5-A0B8675AB611Q28387661-46DC400E-D952-4BA5-8575-27E0E900DE62Q30415505-CEE0E02B-303B-4734-A548-46CDA7D073E7Q33882297-204F95CC-EF36-4DDD-AC17-1F1D28700CE6Q34541350-0E05B18C-D1B4-46BA-9587-6CBAAA73C6C6Q35932966-FD08EBBF-4899-4F67-8E2F-1F91EC170C22Q36021645-CBD5E6EA-DD28-4916-BFFF-DE0E74A6C29CQ36210558-A9724070-6378-4D85-8418-644035AD93D0Q36362712-D45CCD45-6A26-48E4-B906-1CF7495DEA6DQ36979196-E01B94EE-FDFC-417E-9E93-56A001F8986DQ37202978-A0558959-4C5E-41BC-8B7F-4FB212B69189Q37959975-117A25E2-B593-4D83-8E2E-97453FE4BC01Q37979644-5016123C-D28F-4AE4-9D1F-FEF3B2506080Q38127782-DD317C96-6B85-4F85-BF9E-367B800D03D5Q38736964-35536638-0342-4028-9951-78ABF2BECD5BQ39104729-82D48066-3C43-45F4-ABEB-B314D10D817CQ40403668-D40E2B23-6E12-4847-B742-AAC7525DCE7CQ52722150-CCDF778D-869F-4D74-92D1-E98E6CD1F929Q59054771-5B8E6073-71E2-4266-A620-C5270A38F2E0
P2860
Novel endogenous small molecules as the checkpoint controllers in inflammation and resolution: entrée for resoleomics.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Novel endogenous small molecul ...... ution: entrée for resoleomics.
@ast
Novel endogenous small molecul ...... ution: entrée for resoleomics.
@en
type
label
Novel endogenous small molecul ...... ution: entrée for resoleomics.
@ast
Novel endogenous small molecul ...... ution: entrée for resoleomics.
@en
prefLabel
Novel endogenous small molecul ...... ution: entrée for resoleomics.
@ast
Novel endogenous small molecul ...... ution: entrée for resoleomics.
@en
P1476
Novel endogenous small molecul ...... ution: entrée for resoleomics.
@en
P2093
Charles N Serhan
Nan Chiang
P356
10.1016/S0889-857X(03)00117-0
P577
2004-02-01T00:00:00Z